| [1] |
Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs[J]. Cell,2005,122(1):9-12.
|
| [2] |
He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation[J]. Nat Rev Genet,2004,5(7):522-531.
|
| [3] |
Calin GA,Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Genet,2006,6(11):857-866.
|
| [4] |
Demonty G, Bernard-Marty C, Puglisi F, et al. Progress and new standards of care in the management of HER-2 positive breast cancer[J]. Eur J Cancer,2007,43(3):497-509.
|
| [5] |
Burstein HJ. The distinctive nature of HER2-positive breast cancers[J]. N Engl J Med,2005,353(16):1652-1654.
|
| [6] |
Arteaga CL, Sliwkowski MX, Osborne CK, et al. Treatment of HER2-positive breast cancer: current status and future perspectives[J]. Nat Rev Clin Oncol,2011,9(1):16-32.
|
| [7] |
Lowery AJ, Miller N, McNeill RE, et al. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management[J]. Clin Cancer Res,2008,14(2):360-365.
|
| [8] |
Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer[J]. Theranostics,2015,5(10):1122-1143.
|
| [9] |
Griffiths-Jones S, Grocock RJ, van Dongen S, et al. MiRBase:microRNA sequences, targets and gene nomenclature[J]. Nucleic Acids Res,2006,34(Database issue): D140-144.
|
| [10] |
Brown JR, Sanseau P. A computational view of microRNAs and their targets[J]. Drug Discov Today,2005,10(8):595-601.
|
| [11] |
Silva M, Melo SA. Non-coding RNAs in exosomes: new players in cancer biology[J]. Curr Genomics,2015,16(5):295-303.
|
| [12] |
Zhang B, Pan X, Cobb GP, et al. MicroRNAs as oncogenes and tumor suppressors[J]. Dev Biol,2007,302(1):1-12.
|
| [13] |
Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? [J]. Cancer Metastasis Rev,2009, 28(3/4):369-378.
|
| [14] |
Marmor MD, Skaria KB, Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors[J]. Int J Radiat Oncol Biol Phys,2004,58(3):903-913.
|
| [15] |
Mattie MD, Benz CC, Bowers J, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies[J]. Mol Cancer, 2006,5:24.
|
| [16] |
Scott GK, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b[J]. J Biol Chem,2007,282(2):1479-1486.
|
| [17] |
Hofmann MH, Heinrich J, Radziwill G, et al. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells[J]. Mol Cancer Res, 2009, 7(10):1635-1644.
|
| [18] |
Blenkiron C, Goldstein LD, Thorne NP, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype[J]. Genome Biol,2007,8(10): R214.
|
| [19] |
Fang C, Zhao Y, Guo B. MiR-199b-5p targets HER2 in breast cancer cells[J]. J Cell Biochem,2013,114(7):1457-1463.
|
| [20] |
Persson H, Kvist A, Rego N, et al. Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene[J]. Cancer Res,2011,71(1):78-86.
|
| [21] |
Patel Y,Shah N,Lee JS,et al. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth[J]. Oncotarget,2016,7(14):18 295-18 308.
|
| [22] |
Farazi TA, Horlings HM, Ten Hoeve JJ, et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing[J].Cancer Res,2011,71(13):4443-4453.
|
| [23] |
Lee JA, Lee HY,Lee ES,et al. Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast[J]. J Breast Cancer,2011,14(4):269-275.
|
| [24] |
Huang TH, Wu F, Loeb GB, et al. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion[J]. J Biol Chem, 2009,284(27):18 515-18 524.
|
| [25] |
Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J]. Gastroenterology,2007,133(2):647-658.
|
| [26] |
Schramedei K, Mörbt N, Pfeifer G, et al. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4[J]. Oncogene,2011,30(26):2975-2985.
|
| [27] |
Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature,2007,449(7163):682-688.
|
| [28] |
Liu Y, Zhao J, Zhang PY, et al. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis[J]. Med Sci Monit,2012,18(8):BR299-308.
|
| [29] |
Adachi R, Horiuchi S, Sakurazawa Y, et al. ErbB2 down-regulates microRNA-205 in breast cancer[J]. Biochem Biophys Res Commun,2011,411:804-808.
|
| [30] |
Zhu M, Yi M, Kim CH, et al. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage[J]. Genome Biol,2011,12: R77.
|
| [31] |
Mao L, Sun AJ, Wu JZ, et al. Involvement of microRNAs in HER2 signaling and trastuzumab treatment[J]. Tumour Biol,2016,37(12):15 437-15 466.
|
| [32] |
Tashkandi H, Shah N, Patel Y, et al. Identification of new miRNA biomarkers associated with HER2-positive breast cancers [ J].Oncoscience,2015,2(11):924-929.
|
| [33] |
Leivonen SK, Sahlberg KK, Mäkelä R, et al. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth[J]. Mol Oncol,2014,8(1):93-104.
|
| [34] |
Gong C, Yao Y, Wang Y, et al. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer[J]. J Biol Chem,2011,286(21):19 127-19 137.
|
| [35] |
De Mattos-Arruda L,Bottai G,Nuciforo PG,et al. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients[J]. Oncotarget,2015,6(35):37 269-37 280.
|
| [36] |
Ye XM, Zhu HY, Bai WD, et al. Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R[J]. BMC Cancer,2014,14:134.
|
| [37] |
Iorio MV,Casalini P,Piovan C,et al. MicroRNA-205 regulates HER3 in human breast cancer[J]. Cancer Res,2009,69(6):2195-2200.
|
| [38] |
Hsieh AC,Moasser MM. Targeting HER proteins in cancer therapy and the role of the non-target HER3[J]. Br J Cancer,2007,97(4):453-457.
|